Medable Therapeutic Area Pathways

All therapeutic areas face unique challenges but the industry’s challenges are universal.

• Study Start-Up & Enrollment Delays
• Poor Participant Experience
• Inconsistent & Incomplete Data
• High Site Burden
• Lack of Representation

Proven Benefits of DCT Technology:

• Reduced clinical trial cycle times by up to 3 months
• Lower clinical trial screen failure rates
• Fewer clinical trial protocol amendments
• 5-14x NPV measured as the net benefit in total study costs versus upfront investment (phase II & III studies)